Biotech · Private company
AUG Therapeutics
Track this companyFree. Adds AUG Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- AVTX-803Phase 3 · Leukocyte Adhesion DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- AVTX-803 (L-Fucose)Phase 3 · Leukocyte Adhesion DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type IIPHASE3 · RECRUITING · started Apr 10, 2023ClinicalTrials.gov NCT05754450 · fetched Nov 12, 2026
- A Study to Evaluate Efficacy and Safety of AVTX-803 in Patients With Leukocyte Adhesion Deficiency Type IIPHASE3 · RECRUITING · started Jul 28, 2022ClinicalTrials.gov NCT05462587 · fetched Nov 12, 2026